EPISODE · Nov 12, 2025 · 23 MIN
Advancing Early Breast Cancer Decision-Making with Dr. William Audeh
from Health Innovation Matters
Michael chats with Dr. William Audeh, Chief Medical Officer at Agendia. Together, they discuss recent advancements in genomic testing for early-stage breast cancer, how Agendia's MammaPrint® and BluePrint® genomic assays go beyond answering the question of "chemo or no chemo," how decisions based on genomic insights offer improved precision in guiding treatment decisions for patients and their physicians, the future of genomic testing, how the FLEX Study is helping answer clinical questions, and much more. To learn more about Agendia, MammaPrint, and BluePrint, visit www.agendia.com.
NOW PLAYING
Advancing Early Breast Cancer Decision-Making with Dr. William Audeh
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m